$7.90 -0.11 (-1.37%)
11/20/2009 4:00 PM

PDL BioPharma, Inc. (PDLI)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

Current Price $7.90 Mkt Cap $945.4M
Open $8.01 P/E Ratio 4.40
Prev. Close $8.01 Div. (Yield) 1.00 (12.50%)
Daily Range $7.85 - $8.02 Volume 2,836,556
52-Wk Range $5.20 - $9.92 Avg. Daily Vol. 3,248,000

PDLI News and Commentary

Caps

How do you think PDLI will perform vs the S&P 500?

Add Stock to Watchlist

All Members

581 Outperform
34 Underperform
 

All-Star Members

153 Outperform
9 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top PDLI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mmorand (63.18)
Submitted March 25, 2008

PDL Biopharma sold its Antibody company to Genmab. The influx of cash will be used for research.

0 Comments | Reply | Report this Post

tutaemeia (97.21)
Submitted December 20, 2008

No way this guys will have good times soon. The fundamentals talk by themselves:Who will by a company with a P/B of 16x, have a ROE in the last 5y of -11, a P/S of 3,63x? Maybe you are looking for the 62,87% of Dividend Yield (Trailing 12mo.). But… More

1 Comment | Reply | Report this Post
PDLI VS S&P 500 (SPY)

Fools bullish on PDLI are also bullish on:

Fools bearish on PDLI are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about PDLI.

Recs

0
Member Avatar fojaha (65.59) Submitted: 11/11/2009 3:49:00 PM : Outperform Start Price: $8.28 PDLI Score: -4.00

like the div. low p/e. i don't believe Obama/care will bother this one, whichever way it goes.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar Pumpstick (99.73) Submitted: 11/9/2009 3:11:22 PM : Outperform Start Price: $8.16 PDLI Score: -3.25

Yes!

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar kurtdabear (98.06) Submitted: 10/30/2009 3:31:25 PM : Outperform Start Price: $8.41 PDLI Score: -11.23

PDLI's 12% current dividend is just too good to pass up. Also, there's the promise of a hefty special dividend coming up within the next couple months. That should provide some insurance against major declines that might arise from the next down-leg of our bear market or from nationalization of all health-care-related companies by the current socialist government. If the socialists lose in the 2010 mid-term elections, PDLI could do even better over a longer term. Even if the socialists win, it still took Canada more than 2 years to drop the "public-option" charade and switch to full socialist medical mode, so you should be able to escape this and all other health-related equities right around this time next year if it looks like the socialists will retain their national majority.

Report this Post 0 Comments | Reply | Permalink
View All 88 Pitches »

Leaderboard

Find the members with the highest scoring picks in PDLI.

Score Leader

l105

l105 (44.86) Score: +100.60

The Score Leader is the member with the highest score across all their picks in PDLI.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
l105 44.86 3/18/2008 Outperform NS $4.20 +87.91% -12.69% +100.60
mmorand 63.18 3/25/2008 Outperform 3M $4.45 +77.57% -15.85% +93.42 1 Comment
Upmore 98.19 3/12/2008 Outperform 5Y $4.52 +74.78% -13.72% +88.50
p2nigra 66.29 3/25/2008 Outperform 3W $4.58 +72.40% -16.05% +88.45
philistine69 < 20 3/12/2008 Outperform 1Y $4.56 +73.24% -14.31% +87.55
xenorol < 20 3/26/2008 Outperform 1Y $4.72 +67.36% -15.04% +82.40
snickers4niki 58.72 3/31/2008 Outperform NS $4.72 +67.52% -14.36% +81.88
BicaChica 79.58 3/6/2008 Outperform 1Y $4.72 +67.52% -14.24% +81.76
stockcontest 93.13 4/1/2008 Outperform NS $4.78 +65.18% -15.11% +80.29
TigerBean 44.33 3/27/2008 Outperform NS $4.80 +64.57% -14.89% +79.46
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackJMP < 20 3/3/2009 Outperform NS $5.61 +40.76% +57.97% -17.21
TrackWedbush < 20 3/3/2009 Outperform NS $5.70 +38.59% +55.63% -17.04
TrackJPMorgan 73.67 9/11/2008 Underperform NS $8.00 -16.49% -24.43% -7.94 1/5/2009 @ $6.68
TrackEdwardOwens 98.46 8/28/2008 Outperform 1Y $12.46 -29.37% -36.97% +7.60 11/24/2008 @ $8.80 1 Comment
TrackLehmanBros 66.51 12/6/2007 Outperform NS $17.15 -29.39% -10.28% -19.11 3/5/2008 @ $12.11
TrackCreditSuiss 90.95 10/5/2007 Outperform NS $16.53 -36.68% -12.38% -24.30 6/13/2008 @ $10.47
TrackWachovia < 20 10/2/2007 Outperform NS $22.58 -40.04% -10.85% -29.18 4/22/2008 @ $13.54
TrackSoros 24.12 9/30/2007 Outperform NS $14.99 -51.00% -13.94% -37.05 3/31/2008 @ $7.34 1 Comment
TrackEveillard 88.00 9/30/2007 Outperform NS $9.61 -17.83% -24.86% +7.03 1 Comment
TrackBroadpoint.AmTech 71.55 8/21/2007 Outperform NS $10.93 +2.31% -7.35% +9.66 3/5/2008 @ $11.18
TrackJimCramer 36.31 3/26/2007 Outperform 3W $9.08 -12.95% -19.21% +6.26
TrackBroadpoint.AmTech 71.55 11/22/2006 Underperform NS $21.94 -15.68% -0.78% +14.90 3/7/2007 @ $18.50
TrackLazardCapit < 20 11/6/2006 Outperform NS $8.92 -11.43% -15.20% +3.77
TrackNeedham < 20 10/12/2006 Outperform NS $14.01 -32.23% -1.59% -30.64 4/11/2008 @ $9.50
TrackJimCramer 36.31 3/10/2006 Underperform 3W $31.66 -35.57% +11.32% +46.89 3/27/2007 @ $20.40

Featured Broker Partners